Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAccesso Technology Group Regulatory News (ACSO)

Share Price Information for Accesso Technology Group (ACSO)

Share Price is delayed by 15 minutes
Get Live Data
325.00    -2.00 (-0.61%)
Bid:
324.00
Ask:
325.00
Spread: 1.00 (0.309%)
Market Cap: £105.27m
ACSO Live PriceLast checked at - London Stock Exchange

Intraday Accesso Technology Group Share Chart

Further update on the formal sale process

13 Nov 2019 07:00

RNS Number : 1872T
Accesso Technology Group PLC
13 November 2019
 

13 November 2019

 

ACCESSO TECHNOLOGY GROUP PLC 

 

("accesso" or the "Company")

 

Further update on the formal sale process

 

accesso Technology Group plc (AIM: ASCO), the premier technology solutions provider to leisure, entertainment, hospitality, attractions and cultural markets, provides the following update on its announced formal sale process (the "Formal Sale Process") under the City Code on Takeovers and Mergers (the "Code") which remains ongoing.

 

Following receipt of a certain number of refreshed indications of interest over the last several months, the Company and its advisers are continuing to engage in discussions with several parties to determine whether a potential offer for the Company can be delivered at a value that the Board considers attractive to shareholders. The interested parties remain engaged in financial and operational due diligence.

 

This announcement is not a firm intention to make an offer under Rule 2.7 of the Code and there can be no certainty that any offers will be made as a result of the Formal Sale Process, that any sale or other transaction will be concluded, nor as to the terms on which any offer or other transaction may be made.

 The Board reserves the right to alter any aspect of the Formal Sale Process or to terminate it at any time and will make further announcements when appropriate. The Board reserves the right to reject any approach or terminate discussions with any interested party or participant at any time.

 

 

 

For further information please contact:

accesso Technology Group plc

Paul Noland, Chief Executive Officer

John Alder, Chief Financial Officer

+44 (0)118 934 7400

Simon Chisholm, Investor Relations

 

+44 (0)1825 723 440

KeyBanc Capital Markets Inc. (Lead Financial Adviser)

Thomas Mazzucco

Chris Headrick

 

 

US: +1 415 659 0934

US: +1 415 486 3410

 

Canaccord Genuity Limited (Rule 3 Adviser, Nominated Adviser and Joint Broker)

Simon Bridges, Richard Andrews

+44 (0)20 7523 8000

 

Numis Securities Limited (Financial Adviser and Joint Broker)

Simon Willis, Mark Lander

+44 (0)20 7260 1000

FTI Consulting, LLP

Matt Dixon, Chris Birt

+44 (0)20 3727 1000

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
FURBTBLTMBIBBLL
Date   Source Headline
5th Jun 20267:00 amRNSHolding(s) in Company
28th May 20266:00 pmRNSHolding(s) in Company
28th May 20267:00 amRNSResult of AGM
18th May 20267:00 amRNSDirector/PDMR Shareholding
1st May 20267:00 amRNSChief Executive Officer Succession
29th Apr 20267:00 amRNSAnnual Report and Notice of AGM
22nd Apr 20267:00 amRNSAppointment of Non-Executive Director
1st Apr 20267:00 amRNSTotal Voting Rights
30th Mar 20267:00 amRNSAcquisition of Dexibit
30th Mar 20267:00 amRNSFinal Results
20th Mar 20266:05 pmRNSHolding(s) in Company
18th Mar 20264:54 pmRNSCompletion of Tender Offer & Total Voting Rights
13th Mar 20261:34 pmRNSResult of Tender Offer
13th Mar 20261:28 pmRNSResult of General Meeting
11th Feb 20267:00 amRNSTender Offer
10th Feb 20267:00 amRNS-RExpansion of Strategic Partnership with Adyen
6th Feb 20263:06 pmRNSDirector/PDMR Shareholding
2nd Feb 20267:00 amRNSTotal Voting Rights
29th Jan 20267:00 amRNSTrading Update and Tender Offer
9th Jan 20265:30 pmRNSHolding(s) in Company
8th Jan 20267:00 amRNSDirector/PDMR Shareholding
8th Jan 20267:00 amRNSTransaction in Own Shares
7th Jan 20267:00 amRNSTransaction in Own Shares
6th Jan 20267:00 amRNSTransaction in Own Shares
5th Jan 20267:00 amRNSTrading Update
2nd Jan 20267:00 amRNSTotal Voting Rights
2nd Jan 20267:00 amRNSTotal Voting Rights
23rd Dec 20257:00 amRNSTransaction in Own Shares
22nd Dec 20256:02 pmRNSHolding(s) in Company
22nd Dec 20256:02 pmRNSHolding(s) in Company
19th Dec 20257:00 amRNSTransaction in Own Shares
19th Dec 20257:00 amRNSTransaction in Own Shares
18th Dec 20257:00 amRNSTransaction in Own Shares
17th Dec 20257:00 amRNSTransaction in Own Shares
16th Dec 20257:00 amRNSTransaction in Own Shares
15th Dec 202511:33 amRNSHolding(s) in Company
15th Dec 20257:00 amRNSTransaction in Own Shares
12th Dec 20257:00 amRNSTransaction in Own Shares
11th Dec 20257:00 amRNSTransaction in Own Shares
10th Dec 20257:00 amRNSTransaction in Own Shares
9th Dec 20257:00 amRNSTransaction in Own Shares
5th Dec 20257:00 amRNSTransaction in Own Shares
4th Dec 20257:00 amRNSTransaction in Own Shares
3rd Dec 20257:00 amRNSTransaction in Own Shares
2nd Dec 20257:00 amRNSTransaction in Own Shares
1st Dec 20257:00 amRNSTotal Voting Rights
1st Dec 20257:00 amRNSTransaction in Own Shares
28th Nov 20257:00 amRNSTransaction in Own Shares
27th Nov 20257:00 amRNSTransaction in Own Shares
26th Nov 20257:00 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.